122 related articles for article (PubMed ID: 31985850)
21. Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients.
Yakaryilmaz F; Guliter S; Ozenirler S; Erdem O; Akyol G
Curr Ther Res Clin Exp; 2004 May; 65(3):266-77. PubMed ID: 24672082
[TBL] [Abstract][Full Text] [Related]
22. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
Tsutsui M; Tanaka N; Kawakubo M; Sheena Y; Horiuchi A; Komatsu M; Nagaya T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Tanaka E; Sano K
J Clin Gastroenterol; 2010 Jul; 44(6):440-7. PubMed ID: 20104187
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.
Zöhrer E; Alisi A; Jahnel J; Mosca A; Della Corte C; Crudele A; Fauler G; Nobili V
Appl Physiol Nutr Metab; 2017 Sep; 42(9):948-954. PubMed ID: 28511023
[TBL] [Abstract][Full Text] [Related]
25. Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.
Corey KE; Misdraji J; Gelrud L; King LY; Zheng H; Malhotra A; Chung RT
Dig Dis Sci; 2015 Aug; 60(8):2523-8. PubMed ID: 25840922
[TBL] [Abstract][Full Text] [Related]
26. Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients.
Sebastiani G; Saeed S; Lebouche B; de Pokomandy A; Szabo J; Haraoui LP; Routy JP; Wong P; Deschenes M; Ghali P; Klein M;
AIDS; 2020 Feb; 34(2):237-244. PubMed ID: 31651429
[TBL] [Abstract][Full Text] [Related]
27. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
[TBL] [Abstract][Full Text] [Related]
28. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.
Lavine JE
J Pediatr; 2000 Jun; 136(6):734-8. PubMed ID: 10839868
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
[TBL] [Abstract][Full Text] [Related]
30. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
[TBL] [Abstract][Full Text] [Related]
32. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.
Pelusi S; Cespiati A; Rametta R; Pennisi G; Mannisto V; Rosso C; Baselli G; Dongiovanni P; Fracanzani AL; Badiali S; Maggioni M; Craxi A; Fargion S; Prati D; Nobili V; Bugianesi E; Romeo S; Pihlajamaki J; Petta S; Valenti L
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2310-2319.e6. PubMed ID: 30708111
[TBL] [Abstract][Full Text] [Related]
34. COMPARATIVE ANALYSIS OF EFFICIENCY OF URSODEOXYCHOLIC ACID AND COMBINATION OF VITAMIN E AND VITAMIN C IN TREATMENT OF NON-DIABETIC NONALCOHOLIC STEATOHEPATITIS.
Barbakadze G; Khachidze T; Sulaberidze G; Burnadze K; Jebashvili M
Georgian Med News; 2019 Mar; (288):81-85. PubMed ID: 31101782
[TBL] [Abstract][Full Text] [Related]
35. Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis.
Sarkhy AA; Al-Hussaini AA; Nobili V
Saudi J Gastroenterol; 2014; 20(3):143-53. PubMed ID: 24976277
[TBL] [Abstract][Full Text] [Related]
36. Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis.
Pastori D; Baratta F; Carnevale R; Cangemi R; Del Ben M; Bucci T; Polimeni L; Labbadia G; Nocella C; Scardella L; Pani A; Pignatelli P; Violi F; Angelico F
Clin Transl Gastroenterol; 2015 Oct; 6(10):e113. PubMed ID: 26426796
[TBL] [Abstract][Full Text] [Related]
37. Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects.
Newfield RS; Graves CL; Newbury RO; Schwimmer JB; Proudfoot JA; Say DS; Feldstein AE
Pediatr Diabetes; 2019 Feb; 20(1):41-47. PubMed ID: 30467936
[TBL] [Abstract][Full Text] [Related]
38. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
[TBL] [Abstract][Full Text] [Related]
39. Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data.
Arsik I; Frediani JK; Frezza D; Chen W; Ayer T; Keskinocak P; Jin R; Konomi JV; Barlow SE; Xanthakos SA; Lavine JE; Vos MB
Children (Basel); 2018 May; 5(6):. PubMed ID: 29799476
[TBL] [Abstract][Full Text] [Related]
40. Quantitative Liver MRI-Biopsy Correlation in Pediatric and Young Adult Patients With Nonalcoholic Fatty Liver Disease: Can One Be Used to Predict the Other?
Dillman JR; Trout AT; Costello EN; Serai SD; Bramlage KS; Kohli R; Xanthakos SA
AJR Am J Roentgenol; 2018 Jan; 210(1):166-174. PubMed ID: 29045180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
